Objective: Based on findings in animal models of autoimmune optic nerve inflammation, we
have assessed the safety and efficacy of erythropoietin in patients presenting with a first …

Ocrelizumab, a humanized monoclonal anti-CD20 antibody, has shown pronounced effects
in reduction of disease activity in multiple sclerosis (MS) patients and has recently been …

We performed a genome‐wide association study in 1,194 controls and 150 patients with anti‐N‐methyl‐D‐aspartate
receptor (anti‐NMDAR, n = 96) or anti‐leucine‐rich glioma‐…

Background and Objectives To determine the real-world use of rituximab in autoimmune
encephalitis (AE) and to correlate rituximab treatment with the long-term outcome. Methods …

Background Neuroborreliosis represents a relevant infectious disease and can cause a
variety of neurological manifestations. Different stages and syndromes are described and …

Objective Our aim was to assess the real‐world effectiveness of immune checkpoint inhibitors
for treatment of patients with progressive multifocal leukoencephalopathy (PML). Methods …

Multiple sclerosis is a chronic immune mediated demyelinating disease leading to neurological
disabilities that need to be diagnosed and treated early. Guidelines on multiple sclerosis …

Objective: Sjögren's syndrome is a heterogeneous inflammatory disorder frequently involving
peripheral nerves with a wide spectrum of sensory modalities and distribution patterns. …

Synaptophysin is an abundant membrane protein of synaptic vesicles. The objective of this
study was to determine the utility of identifying synaptophysin accumulations (spheroids/…

Objective To assess intensive care unit (ICU) complications, their management, and prognostic
factors associated with outcomes in a cohort of patients with autoimmune encephalitis (…